Evidence map›Paper›PMID 28302638›Full record

ArticleBMJ open2017

Innovative approach for self-management and social welfare of children with cystic fibrosis in Europe: development, validation and implementation of an mHealth tool (MyCyFAPP).

Joaquim Calvo-Lerma, Celia P Martinez-Jimenez, Juan-Pablo Lázaro-Ramos, Ana Andrés, Paula Crespo-Escobar, Erlend Stav, Cornelia Schauber, Lucia Pannese, Jessie M Hulst, Lucrecia Suárez and 5 more

Open access · goldAbstract readValidation Study
In one paragraph

Article in BMJ open, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Mobile health applications designed for self-management of chronic pulmonary diseases in children and adolescents: a systematic mapping review.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2023
    Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 6 countries.

Joaquim Calvo-LermaInstituto de Investigación Sanitaria La Fe. Avenida Fernando Abril Martorell, Valencia, Spain.
Celia P Martinez-JimenezUniversity of Cambridge, Cancer Research UK Cambridge Institute, Cambridge, UK.
Juan-Pablo Lázaro-RamosSoluciones Tecnológicas para la Salud y el Bienestar, Paterna, Spain.
Ana AndrésInstituto de Ingeniería de Alimentos para el Desarrollo, Universitat Politècnica de València, Valencia, Spain.
Paula Crespo-EscobarInstituto de Investigación Sanitaria La Fe. Avenida Fernando Abril Martorell, Valencia, Spain.
Erlend StavSTIFTELSEN SINTEF, Trondheim, Norway.
Cornelia SchauberYOUSE GmbH. Kyreinstraße, München, Germany.
Lucia PanneseImaginary SRL. Piazza Caiazzo, Milano, Italy.
Jessie M HulstErasmus Medical Center, Sophia Children's Hospital, Rotterdam, The Netherlands.
Lucrecia SuárezServicio Madrileño de Salud-Hospital Universitario Ramón y Cajal, Colmenar Viejo, Spain.
Carla ColomboUniversità degli Studi di Milano. Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Celeste BarretoAssociação Portuguesa para a Investigação e Desenvolvimento da Faculdade de Medicina, Lisbon, Portugal.
Kris de BoeckDepartment of Paediatrics, University Hospital of Leuven, University of Leuven, Leuven, Belgium.
Carmen Ribes-KoninckxInstituto de Investigación Sanitaria La Fe. Avenida Fernando Abril Martorell, Valencia, Spain.
MyCyFAPP
Instituto de Investigación Sanitaria La Fe · ESErasmus MC - Sophia Children’s Hospital · NLFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITImaginary (Italy) · ITKU Leuven · BEMadrid Health Service · ESSINTEF · NOTecnologías para la Salud y el Bienestar (Spain) · ESUniversitat Politècnica de València · ESWellcome Sanger Institute · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionFor the optimal management of children with cystic fibrosis, there are currently no efficient tools for the precise adjustment of pancreatic enzyme replacement therapy, either for advice on appropriate dietary intake or for achieving an optimal nutrition status. Therefore, we aim to develop a mobile application that ensures a successful nutritional therapy in children with cystic fibrosis. METHODS AND ANALYSIS: A multidisciplinary team of 12 partners coordinate their efforts in 9 work packages that cover the entire so-called 'from laboratory to market' approach by means of an original and innovative co-design process. A cohort of 200 patients with cystic fibrosis aged 1-17 years are enrolled. We will develop an innovative, clinically tested mobile health application for patients and health professionals involved in cystic fibrosis management. The mobile application integrates the research knowledge and innovative tools for maximising self-management with the aim of leading to a better nutritional status, quality of life and disease prognosis. Bringing together different and complementary areas of knowledge is fundamental for tackling complex challenges in disease treatment, such as optimal nutrition and pancreatic enzyme replacement therapy in cystic fibrosis. Patients are expected to benefit the most from the outcomes of this innovative project. ETHICS AND DISSEMINATION: The project is approved by the Ethics Committee of the coordinating organisation, Hospital Universitari La Fe (Ref: 2014/0484). Scientific findings will be disseminated via journals and conferences addressed to clinicians, food scientists, information and communications technology experts and patients. The specific dissemination working group within the project will address the wide audience communication through the website (http://www.mycyfapp.eu), the social networks and the newsletter.

Indexed as

Child WelfareAdolescentChildChild, PreschoolCystic FibrosisEuropeFemaleHumansInfantMaleProgram EvaluationSelf-ManagementTelemedicineNUTRITION & DIETETICS

Identifiers

PMID28302638
PMCPMC5372031
OpenAlexW2595836823

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.